Amgen, a leading biotechnology company, focuses on discovering, developing, manufacturing, and delivering innovative human therapeutics. The company's primary areas of focus include oncology, hematology, cardiovascular disease, inflammation, bone health, nephrology, and neuroscience. Amgen's business model revolves around leveraging advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. The company's portfolio includes both blockbuster drugs and emerging therapies, which are categorized based on their ...
Classification: Cash Cow Enbrel has been a long-standing product in Amgen's portfolio, contributing significantly to the company's revenue. Its market share remains strong due to its established efficacy, but the market growth is slower due to the presence of newer biologics and biosimilars. Enbrel continues to generate substantial cash flow for Amgen despite the competitive landscape.
Classification: Star Prolia has shown impressive market growth driven by the increasing prevalence of osteoporosis and heightened awareness of b...
Our BCG tool allows you to fill out the matrix with your own products.
It's like ChatGPT but for your university course. Ask questions about your course material and get instant answers with citations.